A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00002168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Randomized, Comparative Study of Zerit (d4T) + Videx (ddI) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml
Study identification
- NCT ID
- NCT00002168
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Indinavir sulfate Drug
- Lamivudine Drug
- Stavudine Drug
- Zidovudine Drug
- Didanosine Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Oct 1, 2007
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Clinic | Berkeley | California | 94705 | — |
| Harbor UCLA Med Ctr / Division of Immunology / N-24 | Torrance | California | 90509 | — |
| Anderson Clinical Research | Washington D.C. | District of Columbia | 20037 | — |
| George Washington Med Ctr / Clinical Trials Unit | Washington D.C. | District of Columbia | 20037 | — |
| Chicago Ctr for Clinical Research | Chicago | Illinois | 60610 | — |
| Northwestern Univ | Chicago | Illinois | 60611 | — |
| Univ of Nebraska | Omaha | Nebraska | 68195 | — |
| Univ of North Carolina / Infectious Disease Division | Chapel Hill | North Carolina | 27599 | — |
| The Nalle Clinic / Clinical Research Dept | Charlotte | North Carolina | 28207 | — |
| Univ of Pennsylvania / Infectious Diseases Division | Philadelphia | Pennsylvania | 19104 | — |
| Southwest Infectious Disease Association / PA | Dallas | Texas | 75225 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2007 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002168 live on ClinicalTrials.gov.